Overview
Marshall Spiegel is a primary care provider, practicing in Internal Medicine in Draper, Utah.
His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
He is actively involved in clinical research, co-authoring 7 peer reviewed articles. Dr. Spiegel is currently accepting new patients.
Specialties
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
11925 S State St, Draper, UT 84020
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Edwards Internal Medicine Outpatient Clinic
PATIENT EDUCATION VIDEOSDr. Woller’s academic interests reside in thrombosis medicine and anticoagulation management. With a particular interest in the prevention of venous thromboembolic disease, Dr. Woller has served as investigator on multiple ongoing and completed clinical trials including the NIH-funded studies. Dr. Woller is Co-Chair for the American College of Chest Physicians (ACCP) Clinical Practice Guideline that addresses antithrombotic therapy for venous thromboembolic disease, and as was a panelist for the Vascular Access Appropriateness Panel housed at the University of Michigan. Dr. Woller is an invited panelist for the Centers for Disease Control and Prevention (CDC) Risk Assessment Model for the Prevention of Venous Thromboembolic Disease in Medical Patients program. Dr. Woller is Professor of Medicine, University of Utah School of Medicine, Professor in Research, Intermountain Healthcare, and is a recognized teacher and recipient of the Intermountain Medical Center Housestaff Teaching Award (2011), the University of Utah School of Medicine Outstanding Faculty Teaching Award (2012), and the University of Utah Department of Internal Medicine Outstanding Faculty Subspecialty Teaching Award (2021, 2024). Dr. Woller, Fellow of the American College of Chest Physicians (FCCP) and Fellow of the American College of Physicians (FACP), served as Utah Chapter Governor of the American College of Physicians (Class of 2025). Dr. Woller's research group was awarded the 2015 U.S. Centers for Disease Control and Prevention (CDC) Healthcare-Associated Venous Thromboembolism (HA-VTE) Prevention Challenge Award. It was with sincere humility and gratitude that Dr. Woller received the Intermountain Health Patient Experience Award (2022, 2024). Dr. Woller received his medical degree from Northwestern University Medical School in 2000. Dr. Woller completed his residency at the University of Utah Hospital (2003) then served as Chief Medical Resident in 2003-04. Dr. Woller is Board Certified in Internal Medicine and attends at the Intermountain Medical Center, Murray UT. Dr. Woller is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Mesenteric Venous Thrombosis, Thrombectomy, and Knee Replacement. Dr. Woller is board certified in American Board Of Internal Medicine. Dr. Woller is currently accepting new patients.
Univ. Of Utah Hosp. Gen. Med. Division
Matthew Rondina is a primary care provider, practicing in Internal Medicine in Salt Lake City, Utah. Dr. Rondina is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Sepsis, Disseminated Intravascular Coagulation, Venous Thromboembolism (VTE), and Blood Clots. Dr. Rondina is board certified in American Board Of Internal Medicine. Dr. Rondina is currently accepting new patients.
Lone Peak Internal Medicine
Jonathan Vellinga is a primary care provider, practicing in Internal Medicine in Draper, Utah. He has been practicing medicine for over 18 years. Dr. Vellinga is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Sulfite Oxidase Deficiency, Hypermethioninemia, Methylmalonic Acidemia with Homocystinuria, and Inborn Amino Acid Metabolism Disorder. Dr. Vellinga is currently accepting new patients.
Frequently Asked Questions about Dr. Marshall L. Spiegel
How do I make an appointment with Dr. Marshall L. Spiegel?
You can book an appointment with Dr. Marshall L. Spiegel by calling their office at 801-783-5011. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Marshall L. Spiegel a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marshall L. Spiegel is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Marshall L. Spiegel specialize in?
While Dr. Marshall L. Spiegel is a Internal Medicine, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Marshall L. Spiegel participate in research or clinical trials?
Yes. Dr. Marshall L. Spiegel has published 7 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Marshall L. Spiegel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Marshall L. Spiegel accept my insurance?
Dr. Marshall L. Spiegel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-783-5011 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerDr. Spiegel isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Spiegel isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Spiegel isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
